AngioDynamics (AngioDynamics) Days Payable

: 84.47 (As of Feb. 2024)

View and export this data going back to 2004. Start your Free Trial

AngioDynamics's average Accounts Payable for the three months ended in Feb. 2024 was $36.4 Mil. AngioDynamics's Cost of Goods Sold for the three months ended in Feb. 2024 was $39.3 Mil. Hence, AngioDynamics's Days Payable for the three months ended in Feb. 2024 was 84.47.

The historical rank and industry rank for AngioDynamics's Days Payable or its related term are showing as below:

ANGO' s Days Payable Range Over the Past 10 Years
Min: 39.29 Med: 57.16 Max: 78.51
Current: 78.51

During the past 13 years, AngioDynamics's highest Days Payable was 78.51. The lowest was 39.29. And the median was 57.16.

ANGO's Days Payable is ranked better than
53.68% of 788 companies
in the Medical Devices & Instruments industry
Industry Median: 73.99 vs ANGO: 78.51

AngioDynamics's Days Payable increased from Feb. 2023 (79.76) to Feb. 2024 (84.47). It may suggest that AngioDynamics delayed paying its suppliers.

AngioDynamics Days Payable Historical Data

The historical data trend for AngioDynamics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Days Payable

61.46

67.18

52.66

57.82

75.98

AngioDynamics Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Days Payable																79.76	77.59	77.09	73.42	84.47

Competitive Comparison

For the Medical Instruments & Supplies subindustry, AngioDynamics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AngioDynamics Days Payable Distribution

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Days Payable distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Days Payable falls into.

AngioDynamics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

AngioDynamics's Days Payable for the fiscal year that ended in May. 2023 is calculated as

	Days Payable (A: May. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: May. 2022 )	+	Accounts Payable (A: May. 2023 ))	/	count )	/	Cost of Goods Sold (A: May. 2023 )	*	Days in Period
=	( (28.047	+	40.445)	/	2 )	/	164.506	*	365
=	34.246					/	164.506	*	365
=	75.98

AngioDynamics's Days Payable for the quarter that ended in Feb. 2024 is calculated as:

	Days Payable (Q: Feb. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Nov. 2023 )	+	Accounts Payable (Q: Feb. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Feb. 2024 )	*	Days in Period
=	( (37.65	+	35.152)	/	2 )	/	39.321	*	365 / 4
=	36.401					/	39.321	*	365 / 4
=	84.47

AngioDynamics Days Payable Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioDynamics (AngioDynamics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (NAS:ANGO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

UG2:Germany

Address

14 Plaza Drive, Latham, NY, USA, 12110

Website

https://www.angiodynamics.com

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

Executives

Lorinda Burgess	director	22 WEST FRONTAG ROAD, NORTHBROOK IL 60093
Karen A Licitra	director	C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Michael E Tarnoff	director	C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Scott Centea	officer: SVP/GM, VIT	C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Dave Helsel	officer: SVP Global Operations and R&D	400 WOOD ROAD, BRAINTREE MA 02184
Laura Piccinini	officer: SVP International	C/O ANGIODYNAMICS INC., 14 PLAZA DRIVE, LATHAM NY 12110
Stephen A Trowbridge	officer: SVP and General Counsel	14 PLAZA DRIVE, LATHAM NY 120110
James C Clemmer	director, officer: President and CEO	COVIDIEN PLC, 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Wesley Johnson	director
Chad Thomas Campbell	officer: SVP/GM, Vascular Access	140 POKANOKET PATH, WRENTHAM MA 02093
Warren Jr Nighan	officer: SVP Quality and Regulatory	ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Richard C Rosenzweig	officer: SVP and General Counsel	C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kevin J Gould	director	247 WASHINGTON STREET, DUXBURY MA 02332
Brent J. Boucher	officer: SVP and GM of Oncology	14 PLAZA DRIVE, LATHAM NY 12110
Michael Greiner	officer: EVP and CFO	C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421